Pharmacogenomics Journal

Papers
(The H4-Index of Pharmacogenomics Journal is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data55
The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data41
Economic evaluation in psychiatric pharmacogenomics: a systematic review35
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs30
A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy22
Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression Study21
Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis20
Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection18
Nine-gene pharmacogenomics profile service: The Mayo Clinic experience18
Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle17
Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan16
Does the RAAS play a role in loss of taste and smell during COVID-19 infections?15
Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review14
Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States14
0.032121896743774